Drug · DIN 02237971
SAIZEN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 26, 1999; first marketed October 26, 1999.
- Drug Identification Number (DIN)
- 02237971
- Company (DIN owner)
- Emd Serono A Division Of Emd Inc CanadaMississauga, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Powder For Solution
- Route
- Intramuscular; Subcutaneous
- Therapeutic class (ATC)
- Somatropin H01AC01
- Class
- Human
- Record last updated
- August 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SOMATROPIN | 5 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 13, 1998: NOC 3207Supplement to a New Drug Submission (SNDS) · New manufacturing facilities & new strength
Other DINs named SAIZEN
- DIN 02350122 · Marketed
- DIN 02350130 · Marketed
- DIN 02350149 · Marketed
- DIN 02237970 · Cancelled Pre Market